Patents by Inventor Patrick John Smith

Patrick John Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250339407
    Abstract: A formulation of a single phase solution, including aminopenicillin, a stabilizing agent, and water. The aminopenicillin in the solution has a potency of 87% or higher at 24 hours of storage at room temperature. A formulation of a single phase solution, including amoxicillin, ampicillin, and/or a combination thereof, a stabilizing agent, and water. The amoxicillin, ampicillin, and/or a combination thereof in the solution has a potency of 87% or higher at 24 hours of storage at room temperature. A formulation of a single phase solution, including amoxicillin, a stabilizing agent, and water. The amoxicillin in the solution has a potency of 87% or higher at 24 hours of storage at room temperature. A formulation of a single phase solution, including ampicillin, a stabilizing agent, and water.
    Type: Application
    Filed: July 15, 2025
    Publication date: November 6, 2025
    Inventors: Patrick John Smith, Patrick Leon Soderlund, William Anthony Soderlund, JR.
  • Publication number: 20250288557
    Abstract: Formulations and methods for treatment of coccidia infections in an animal. The method includes obtaining a formulation of Statin (e.g., Atorvastatin), Indomethacin, Doxycycline, Cimetidine, Lincomycin, Sulfamethoxazole, Trimethoprim, Diclazuril, Salinomycin, Budesonide, Amprolium, Azithromycin, and/or any combination thereof; and providing the formulation to an animal.
    Type: Application
    Filed: May 30, 2025
    Publication date: September 18, 2025
    Inventors: William Anthony Soderlund, JR., Patrick Leon Soderlund, Patrick John Smith, Alyssa Louise Real
  • Patent number: 12409168
    Abstract: A formulation of a single phase solution, including aminopenicillin, a stabilizing agent, and water. The aminopenicillin in the solution has a potency of 87% or higher at 24 hours of storage at room temperature. A formulation of a single phase solution, including amoxicillin, ampicillin, and/or a combination thereof, a stabilizing agent, and water. The amoxicillin, ampicillin, and/or a combination thereof in the solution has a potency of 87% or higher at 24 hours of storage at room temperature. A formulation of a single phase solution, including amoxicillin, a stabilizing agent, and water. The amoxicillin in the solution has a potency of 87% or higher at 24 hours of storage at room temperature. A formulation of a single phase solution, including ampicillin, a stabilizing agent, and water.
    Type: Grant
    Filed: August 16, 2024
    Date of Patent: September 9, 2025
    Assignee: VETERINARY PHARMACY CORPORATION
    Inventors: Patrick John Smith, Patrick Leon Soderlund, William Anthony Soderlund, Jr.
  • Publication number: 20250057818
    Abstract: A formulation of a single phase solution, including aminopenicillin, a stabilizing agent, and water. The aminopenicillin in the solution has a potency of 87% or higher at 24 hours of storage at room temperature. A formulation of a single phase solution, including amoxicillin, ampicillin, and/or a combination thereof, a stabilizing agent, and water. The amoxicillin, ampicillin, and/or a combination thereof in the solution has a potency of 87% or higher at 24 hours of storage at room temperature. A formulation of a single phase solution, including amoxicillin, a stabilizing agent, and water. The amoxicillin in the solution has a potency of 87% or higher at 24 hours of storage at room temperature. A formulation of a single phase solution, including ampicillin, a stabilizing agent, and water.
    Type: Application
    Filed: August 16, 2024
    Publication date: February 20, 2025
    Inventors: Patrick John Smith, Patrick Leon Soderlund, William Anthony Soderlund, JR.
  • Publication number: 20240316244
    Abstract: A liquid bandage which includes two or more topical antibiotics, and a silica-based colloid. The topical antibiotics can be, at least, neomycin, bacitracin, or both. The silica-based colloid can be colloidal silicon dioxide. The liquid bandage can also include simethicone. Applying the liquid bandage can be done by using a spraying device, wherein the liquid bandage is in liquid form and is applied onto a wound of an animal, such as for example, a tail bite wound of a pig.
    Type: Application
    Filed: March 22, 2024
    Publication date: September 26, 2024
    Inventor: Patrick John Smith
  • Publication number: 20240207283
    Abstract: The disclosure herein describes solubilizing an insoluble compound in water forming a complex with a hydrotrope and controlling the pH of the water or water-based solution. In some embodiments, methods for solubilizing a compound, such as meloxicam or piroxicam, in water are described. These methods can include forming a colloidal suspension of the compound, and then forming an aqueous colloidal suspension from the colloidal suspension.
    Type: Application
    Filed: May 27, 2022
    Publication date: June 27, 2024
    Inventor: Patrick John SMITH
  • Publication number: 20240197632
    Abstract: The disclosure herein describes solubilizing an ibuprofen in water forming a complex with a hydrotrope and controlling the pH of the water or water-based solution. The methods for solubilizing ibuprofen in water are described. These methods can include forming a colloidal suspension of the ibuprofen, and then forming an aqueous colloidal suspension from the colloidal suspension.
    Type: Application
    Filed: January 29, 2024
    Publication date: June 20, 2024
    Inventor: Patrick John Smith